McKesson Pharmacy Systems and Automation (MPS&A) is testing a new solution designed to help pharmacies improve their rating for patient medication adherence.

McKesson Pharmacy Systems and Automation, MPS&A, Adherence Performance, reporting solution, pilot, patient medication adherence, adherence rating, Centers for Medicare & Medicaid Services, CMS, Star Ratings, Emilie Ray, Adherence Performance reporting solution, Business Optimization solution, Adherence Performance pilot, Business Optimization reports

Other Services
Reprints / E-Prints
Submit News
White Papers

Retail News Breaks Archives

McKesson pilots solution to lift pharmacy Rx adherence ratings

June 5th, 2014

PITTSBURGH – McKesson Pharmacy Systems and Automation (MPS&A) is testing a new solution designed to help pharmacies improve their rating for patient medication adherence.

MPS&A said Thursday that it has launched a pilot program for its Adherence Performance reporting solution, which provides pharmacies with an adherence rating similar to the Centers for Medicare & Medicaid Services (CMS) Star Ratings provided to health plans.

The solution is intended to help pharmacies better understand their adherence rating by organizing pharmacy management system data and providing pharmacies succinct information on target patients who should be included in an adherence program.

Plans call for MPS&A to test the Adherence Performance solution in three pharmacy settings: large chain, outpatient and small independent.

"Our Adherence Performance reporting solution helps each pharmacy focus on a group of specific patients whose medication adherence behavior has the most negative impact on the pharmacy's adherence rating," according to Emilie Ray, president of MPS&A. "Rather than leaving our pharmacies to sift through charts and spreadsheets generated from other reports, we've created a real-time set of reports to give pharmacists the information they need to take swift action with specific patients."

Pharmacies using the MPS&A's new adherence solution receive a variety of reports. A dashboard summary shows the pharmacy's overall adherence rating for all locations and provides benchmarking data depicting how that pharmacy compares with the rest of its market. The dashboard also shows the pharmacy's adherence rating trend over time.

Another report gives adherence ratings by location, enabling pharmacies to see which stores or facilities have higher and/or lower ratings. In turn, this allows them to target improvement plans by location, MPS&A noted.

Other reports include adherent patient target number, which specifies how many additional patients need to be adherent to increase the rating, and adherence rating by plan, which enables pharmacies to share their current adherence rating and improvement over time with health plans. Also, a target patient list indicates patients to target for an adherence program, and a patient group summary sets up a report by patient group in the pharmacy management system.

MPS&A added that the Adherence Performance solution is the second offering from its Informatics Program, which focuses on providing pharmacies with actionable data. The first, its Business Optimization solution, was released to large chain and outpatient pharmacies last year. The reports focus on operations analysis and highlight actions that pharmacies can take to boost efficiency and mitigate the cost of business.

"Within a few months of introducing our Business Optimization reports, we helped some customers increase their central fill pull-through rates to save thousands of dollars per month on inventory costs," Ray stated. "We also pinpointed areas for efficiency improvement during dispensing that helped a customer reduce wait times by 38%. Based on these results, we're confident that our Adherence Performance reports will bring results for our customers too."

MPS&A said that when the Adherence Performance pilot finishes, the solution will be made generally available to its customers. The company added that it plans to release its Business Optimization reports to the small independent market in the coming months.